Cognitive disorder NOS

Verify with FDA CVM →

VeDDRA Code: 1382

260 adverse event reports referencing this reaction

260
Total Reports
71
Deaths
2730.0%
Death Rate

Species Most Affected

Dog 246
Cat 13
Human 1

Breeds Most Affected

Retriever - Labrador 24
Dog (unknown) 19
Crossbred Canine/dog 14
Chihuahua 14
Beagle 10
Terrier - Yorkshire 9
Terrier - Jack Russell 8
Shepherd Dog - Australian 8
Shepherd Dog - German 8
Domestic Shorthair 7

Associated Drugs

Bedinvetmab 118
Trilostane 77
Carprofen 30
Gabapentin 28
Milbemycin Oxime + Spinosad 10
Pimobendan 10
Grapiprant 9
Pyrantel Pamoate;Sarolaner 9
Galliprant 9
Enalapril 8
Trazodone 8
Fluralaner 13.64% 12-Week Chew 7
Denamarin 6
Afoxolaner 5
Prednisone 5
Metronidazole 5
Frunevetmab 5
Keppra 5
Alprazolam 4
Buprenorphine 4

Data Summary

Metric Value
Total reports referencing reaction 260
Reports with fatal outcome 71
Case-fatality rate (reported events) 2730.0%
Species observed 3
Breeds observed 20
Drugs associated with reaction 20

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER); reaction term coded under VeDDRA 1382.

Cognitive disorder NOS Reaction Insights

The FDA Center for Veterinary Medicine database currently lists 260 adverse event reports that reference Cognitive disorder NOS as a reaction term, including 71 reports with a death outcome — a 2730.0% case-fatality figure calculated across only those events where this reaction was coded. The reaction is indexed in the openFDA system under VeDDRA code 1382, the standardized veterinary dictionary used to normalize clinical signs across submitters. Because reports are voluntary and often describe multiple concurrent signs per animal, the volume here reflects reporting intensity rather than true incidence in the broader pet population.

Cognitive disorder NOS appears most frequently in reports for Dog (246 reports), Cat (13 reports), Human (1 reports) — with Dog dominating at 246 entries. Within those species, the breeds most often named alongside this reaction are Retriever - Labrador (24), Dog (unknown) (19), Crossbred Canine/dog (14). These distributions are influenced both by underlying breed popularity and by how veterinarians and owners code a given clinical sign, so they should be interpreted as a reporting fingerprint rather than a pure susceptibility ranking.

The drugs most commonly co-reported with Cognitive disorder NOS are Bedinvetmab (118 reports), Trilostane (77 reports), Carprofen (30 reports), Gabapentin (28 reports), with Bedinvetmab appearing alongside this reaction in 118 submissions. Co-reporting does not establish that any specific product caused the reaction — FDA CVM data captures temporal association only. The value of these aggregates is in flagging which therapeutic classes appear repeatedly alongside a given clinical sign, so owners and veterinarians can ask targeted questions about medications currently in use.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial